title: Effect of paf antagonists on the cytotoxic activity of antineoplastic ether phospholipids.
abstract: The capability of the methoxy-substituted 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3 or Edelfosine) and the two aza-alkylphospholipids BN 52205 and BN 52211 to bind to the PAF receptor was analysed in rabbit platelet membranes. Ether phospholipid concentrations were tested between 10(-5) M and 10(-11) M. The results indicate that ether phospholipids are not able to bind to the PAF receptor and do not prevent PAF binding to its receptor. Moreover, the cytotoxic effect of three potent PAF antagonists, BN 52021, BN 50730 and BN 50739, were analysed in HL60 promyelocytic cells. These cells were pre-and co-treated with PAF antagonists and ether phospholipids. The data show that the three PAF antagonists failed to counteract the activity of ET-18-OCH3, BN 52205 and BN 52211 thus demonstrating that the cytotoxic effect of these new anti-neoplastic drugs is not mediated by the PAF receptor.
authors.affiliation: INST HENRI BEAUFOUR,F-91952 LES ULIS,FRANCE.
authors.forename: L
authors.initials: L
authors.lastname: Diomede
authors.forename: P
authors.initials: P
authors.lastname: Principe
authors.forename: M
authors.initials: M
authors.lastname: Domingo
authors.forename: C
authors.initials: C
authors.lastname: Broquet
authors.forename: P
authors.initials: P
authors.lastname: Chabrier
authors.forename: P
authors.initials: P
authors.lastname: Braquet
authors.forename: M
authors.initials: M
authors.lastname: Salmona